Obtelecare

05/10/2026

Today, we’re celebrating the reason behind everything we do.

Mothers are at the center of our mission, guiding the care we deliver, the partnerships we build, and the impact we strive to make every day.

To all the mothers, mothers-to-be, and those who support them: thank you, and Happy Mother’s Day! 💙

05/05/2026

Join Obtelecare and Teladoc Health at NEXUS 2026, hosted by the American Telemedicine Association.

Visit us at booth 224 for a live demo and see how our teleMFM service—powered by Teladoc Health’s Solo™ Enterprise Solution and staffed by Obtelecare—is expanding access to maternal-fetal medicine and supporting patients with high-risk pregnancies.

Experience how the Solo™ virtual care platform seamlessly connects patients and hospital care teams with board-certified MFMs in real time!

📅 May 12–14, 2026
📍 Hyatt Regency Grand Cypress, Orlando, FL

05/01/2026

May is National Preeclampsia Awareness Month.

Preeclampsia is one of the leading causes of maternal and neonatal complication, and it can escalate quickly, often without obvious warning signs. The difference between a manageable condition and a life-threatening emergency often comes down to early detection and timely intervention.

But early detection isn’t possible without access. Across the U.S., too many patients still face barriers to consistent prenatal care and specialty support—especially in communities with limited maternal-fetal medicine resources.

Raising awareness is critical. So is continuing to expand access to the expertise that helps identify and manage high-risk pregnancies before they become emergencies.

04/28/2026

At this year’s Becker’s Healthcare Annual Meeting, one message stood out.

The question is no longer if telehealth has a place in maternal care delivery, but how it can be implemented effectively, sustainably, and at scale.

Healthcare leaders are focused on how to scale and sustain solutions that expand access, support care teams, and deliver measurable outcomes.

In partnership with Teladoc Health, we demonstrated how teleMFM works in practice—and why it’s becoming a core part of care delivery.

Here’s what we’re hearing: https://obtelecare.com/what-we-heard-at-beckers-key-takeaways-on-telemedicine-from-healthcare-leaders/

04/23/2026

Are you attending the 75th American College of Obstetricians & Gynecologists - ACOG Annual Clinical & Scientific Meeting in Washington, DC?

Stop by and say hello to Dr. Jeff Chapa, our National Medical Director of Maternal-Fetal Medicine!

He'll be at the booth 222 with the Ob Hospitalist Group team, connecting with clinicians about the future of obstetrics and maternal-fetal medicine!

We’re excited to be in Washington, DC for the American College of Obstetricians & Gynecologists - ACOG Annual Clinical & Scientific Meeting.

Between the cherry blossoms and conversations shaping the future of maternal care, there’s no better place to connect.

If you’re attending May 1–3, stop by Booth #222 and say hello. We’d love to meet you!

04/23/2026

$206M in federal funding presents a major opportunity to reshape rural healthcare in Mississippi. The question is how it will be used—and where it will make the greatest impact.

In a recent op-ed, Memorial Health System CEO Kent Nicaud outlines why maternal health must be at the center of that strategy. Memorial Hospital Gulfport has already taken steps in this direction by expanding access to maternal-fetal medicine through a telehealth partnership with Obtelecare and Teladoc Health

As states evaluate similar investments, building teleMFM into rural health strategies will be critical to expanding access for families and supporting perinatal care teams.

Read the full op-ed here: https://mississippitoday.org/2026/04/17/maternal-care-rural-hospitals-rural-health/

04/21/2026

“Wild pregnancy” is trending—and gaining attention after HBO’s The Pitt.

But skipping prenatal care can mean missing serious, even life-threatening complications for both mom and baby.

So why are more women choosing this path? And what are the risks?

Read the full article, featuring our own Dr. Jeffrey Chapa: https://www.womansworld.com/wellness/wild-pregnancy-trend-on-the-pitt-finale-alarms-doctors

04/17/2026

Black women in the U.S. continue to face significantly higher risks in pregnancy and childbirth.

For Black Maternal Health Week, Dr. Nicole Plenty, a Maternal-Fetal Medicine clinician at Obtelecare, shares what she sees in practice: the disparities Black women face, why representation matters, and how access to care can—and must—improve.

Take a few minutes to listen. 🎥

04/15/2026

It’s day 3 of the Becker's Hospital Review 16th Annual Meeting! Today is your last chance to stop by booth 417 for a live demo of Obtelecare's teleMFM service, powered by Teladoc Health’s Solo Enterprise Solution.

Come say hello and learn how we’re working together to bring maternal-fetal medicine care to more high-risk patients nationwide.

04/10/2026

Access to maternal-fetal medicine is shrinking as the need for MFMs is continuing to grow.

A recent statement from the Society for Maternal Fetal Medicine highlights a widening workforce gap, expanding maternity care deserts, and the direct impact on maternal and neonatal outcomes.

But there is a path forward.

Through new care delivery models like teleMFM, hospitals have an opportunity to expand access and better support high-risk patients, no matter where they live.

Read more about what this means for the future of maternal care on our blog. Link in the comments!

04/04/2026

It's 2026 in the United States of America. That means more patients are receiving early prenatal care than ever before—right?

The reality may surprise you.

Data from the March of Dimes shows that in 2025, 24.5% of pregnant patients—nearly 1 in 4—did not begin prenatal care in the first trimester, marking the fourth consecutive year of decline.

At the same time, preexisting conditions like hypertension and diabetes are rising, making early, specialized care more critical than ever.

These trends highlight a growing gap in maternal care and an opportunity to expand access to maternal-fetal medicine and support better outcomes for high-risk pregnancies.